These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 15324908)
1. Formation of squaric acid amides of anthracycline antibiotics. Synthesis and cytotoxic properties. Tevyashova A; Sztaricskai F; Batta G; Herczegh P; Jeney A Bioorg Med Chem Lett; 2004 Sep; 14(18):4783-9. PubMed ID: 15324908 [TBL] [Abstract][Full Text] [Related]
2. A new class of semisynthetic anthracycline glycoside antibiotics incorporating a squaric acid moiety. Sztaricskai F; Sum A; Roth E; Pelyvás IF; Sándor S; Batta G; Herczegh P; Reményi J; Miklán Z; Hudecz F J Antibiot (Tokyo); 2005 Nov; 58(11):704-14. PubMed ID: 16466024 [TBL] [Abstract][Full Text] [Related]
3. Influence of the structure of new anthracycline antibiotics on their biological properties. Wasowska M; Oszczapowicz I; Wietrzyk J; Opolski A; Madej J; Dzimira S; Oszczapowicz J Anticancer Res; 2005; 25(3B):2043-8. PubMed ID: 16158943 [TBL] [Abstract][Full Text] [Related]
4. Inhibitory activity of four demethoxy fluorinated anthracycline analogs against five human-tumor cell lines. Horton D; Khare A Bioorg Med Chem Lett; 2010 Nov; 20(21):6179-81. PubMed ID: 20850305 [TBL] [Abstract][Full Text] [Related]
5. Effect of structural modifications of anthracyclines on the ability to overcome drug resistance of cancer cells. Wasowska M; Wietrzyk J; Opolski A; Oszczapowicz J; Oszczapowicz I Anticancer Res; 2006; 26(3A):2009-12. PubMed ID: 16827137 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and antitumor activity of novel 3,4-diaryl squaric acid analogs. Liu ZY; Wang YM; Han YX; Liu L; Jin J; Yi H; Li ZR; Jiang JD; Boykin DW Eur J Med Chem; 2013 Jul; 65():187-94. PubMed ID: 23708012 [TBL] [Abstract][Full Text] [Related]
7. Synthesis of daunorubicin analogues containing truncated aromatic cores and unnatural monosaccharide residues. Fan E; Shi W; Lowary TL J Org Chem; 2007 Apr; 72(8):2917-28. PubMed ID: 17373847 [TBL] [Abstract][Full Text] [Related]
8. Modification of the antibiotic olivomycin I at the 2'-keto group of the side chain. Novel derivatives, antitumor and topoisomerase I-poisoning activity. Tevyashova AN; Olsufyeva EN; Balzarini J; Shtil AA; Dezhenkova LG; Bukhman VM; Zbarsky VB; Preobrazhenskaya MN J Antibiot (Tokyo); 2009 Jan; 62(1):37-41. PubMed ID: 19132061 [TBL] [Abstract][Full Text] [Related]
9. New anthracycline antibiotics 10-epi-oxaunomycin and 10-epi-11-deoxyoxaunomycin. Johdo O; Nishida H; Okamoto R; Yoshimoto A; Takeuchi T J Antibiot (Tokyo); 1995 Oct; 48(10):1153-8. PubMed ID: 7490224 [TBL] [Abstract][Full Text] [Related]
11. Synthesis of a 200-member library of squaric acid N-hydroxylamide amides. Charton J; Leroux F; Delaroche S; Landry V; Déprez BP; Déprez-Poulain RF Bioorg Med Chem Lett; 2008 Sep; 18(18):4968-71. PubMed ID: 18760922 [TBL] [Abstract][Full Text] [Related]
12. A short and efficient transformation of rhamnose into activated daunosamine, acosamine, ristosamine and epi-daunosamine derivatives, and synthesis of an anthracycline antibiotic acosaminyl-epsilon-iso-rhodomycinone. Renneberg B; Li YM; Laatsch H; Fiebig HH Carbohydr Res; 2000 Dec; 329(4):861-72. PubMed ID: 11125829 [TBL] [Abstract][Full Text] [Related]
13. Crystal structures and spectroscopic properties of ester amide and diamide of squaric acid with prolinamide. Kolev T; Seidel RW; Mayer-Figge H; Spiteller M; Sheldrick WS; Koleva BB Spectrochim Acta A Mol Biomol Spectrosc; 2009 Apr; 72(3):502-9. PubMed ID: 19101193 [TBL] [Abstract][Full Text] [Related]
14. Cytotoxic activity of some glycoconjugates including saponins and anthracyclines. Ekholm FS; Berényi Á; Lagerquist L; Saloranta T; Zupkó I; Schneider G; Wölfling J; Leino R Carbohydr Res; 2012 Jul; 356():295-8. PubMed ID: 22520504 [TBL] [Abstract][Full Text] [Related]
15. Discovery of 2-arylthiazolidine-4-carboxylic acid amides as a new class of cytotoxic agents for prostate cancer. Gududuru V; Hurh E; Dalton JT; Miller DD J Med Chem; 2005 Apr; 48(7):2584-8. PubMed ID: 15801848 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and antiproliferative activity of 2-aryl-4-oxo-thiazolidin-3-yl-amides for prostate cancer. Gududuru V; Hurh E; Dalton JT; Miller DD Bioorg Med Chem Lett; 2004 Nov; 14(21):5289-93. PubMed ID: 15454213 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and activity evaluation of a new bestatin derivative LYP2 as an aminopeptidase N inhibitor. Luan Y; Wang Q; Liu N; Mou J; Jiao X; Fang H; Li M; Xu W Anticancer Drugs; 2011 Jan; 22(1):99-103. PubMed ID: 21048494 [TBL] [Abstract][Full Text] [Related]
18. Structural requirements for the formation of anthracycline-DNA adducts. Cutts SM; Parker BS; Swift LP; Kimura KI; Phillips DR Anticancer Drug Des; 2000 Oct; 15(5):373-86. PubMed ID: 11354313 [TBL] [Abstract][Full Text] [Related]
19. Triphenylmethylamides (TPMAs): Structure-activity relationship of compounds that induce apoptosis in melanoma cells. Palchaudhuri R; Hergenrother PJ Bioorg Med Chem Lett; 2008 Nov; 18(22):5888-91. PubMed ID: 18710803 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of antitumoral activity of ester and amide derivatives of 2-arylamino-6-trifluoromethyl-3-pyridinecarboxylic acids. Onnis V; Cocco MT; Lilliu V; Congiu C Bioorg Med Chem; 2008 Mar; 16(5):2367-78. PubMed ID: 18065230 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]